Form 8-K - Current report:
SEC Accession No. 0001213900-16-009965
Filing Date
2016-01-07
Accepted
2016-01-07 15:50:10
Documents
2
Period of Report
2016-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k010416_immucellcorp.htm 8-K 15439
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED JANUARY 6, 2016 f8k010416ex99i_immucell.htm EX-99.1 13358
  Complete submission text file 0001213900-16-009965.txt   29831
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 161330234
SIC: 2835 In Vitro & In Vivo Diagnostic Substances